Department of Radiology, University of Virginia Health System, Box 800170, Lee Street, Charlottesville, VA 22908, USA.
J Vasc Interv Radiol. 2010 Oct;21(10):1501-7. doi: 10.1016/j.jvir.2010.05.021.
To review an experience with the Amplatzer vascular plug (AVP) for prevention of type II endoleaks during endovascular aneurysm repair (EVAR) of thoracic and thoracoabdominal aneurysms.
Retrospective review was undertaken of 14 patients undergoing transcatheter occlusion of the left subclavian (n = 12) or celiac artery (n = 2) with the AVP as part of EVAR of thoracic and thoracoabdominal aneurysms at a single institution. Procedural criteria evaluated were success at target vessel occlusion, the number of AVPs used, use of adjunctive embolization devices, and embolization-related ischemic end-organ events. Follow-up imaging criteria included evaluation of persistent target vessel occlusion, evidence of device migration, and the presence and characterization of endoleak secondary to AVP failure.
Complete target vessel occlusion was documented for all cases. In six cases, more than one AVP was placed, with an average of 1.5 devices per patient. In two cases, adjunctive coils were placed. Computed tomographic or magnetic resonance angiography follow-up was available for all patients (mean follow-up, 419 days; range 28-930 d). No case showed evidence of device migration or type II endoleak resulting from AVP failure. There was a single instance of left subclavian artery recanalization without type II endoleak. There were no embolization-related ischemic end-organ events.
Transcatheter arterial occlusion of the subclavian and celiac arteries with the AVP is a valuable adjunct to endografting in cases in which side branch embolization is necessary to extend the landing zone.
回顾使用 Amplatzer 血管塞(AVP)预防胸主动脉瘤和胸腹主动脉瘤血管内修复(EVAR)中 II 型内漏的经验。
回顾性分析了 14 例在一家医院接受经导管左锁骨下动脉(n=12)或腹腔动脉(n=2)闭塞术治疗的患者,这些患者在胸主动脉瘤和胸腹主动脉瘤的 EVAR 中使用 AVP。评估的程序标准包括目标血管闭塞的成功率、使用的 AVP 数量、辅助栓塞装置的使用以及与栓塞相关的缺血终末器官事件。随访影像学标准包括评估目标血管持续闭塞、器械迁移的证据以及由于 AVP 失败导致的内漏的存在和特征。
所有病例均证实完全闭塞了目标血管。在 6 例中,放置了多个 AVP,每个患者平均使用 1.5 个装置。在 2 例中,使用了辅助线圈。所有患者均进行了计算机断层扫描或磁共振血管造影随访(平均随访时间为 419 天;范围为 28-930 天)。没有病例显示器械迁移或由于 AVP 失败导致的 II 型内漏。仅有 1 例左锁骨下动脉再通而无 II 型内漏。没有与栓塞相关的缺血终末器官事件。
对于需要侧支栓塞来延长着陆区的病例,使用 AVP 经导管动脉闭塞左锁骨下动脉和腹腔动脉是血管内修复的有价值的辅助手段。